MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy.
BACKGROUND: The surrogate markers of HIV/AIDS progression include CD4 T cell count and plasma viral load. But, their reliability has been questioned in patients on anti-retroviral therapy (ART). Five microRNAs (miRNAs) - miR-16, miR-146b-5p, miR-150, miR-191 and miR-223 in peripheral blood mononucle...
Main Authors: | Saif Ullah Munshi, Harekrushna Panda, Prasida Holla, Bharat Bhushan Rewari, Shahid Jameel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4020752?pdf=render |
Similar Items
-
Nuclear magnetic resonance based profiling of biofluids reveals metabolic dysregulation in HIV-infected persons and those on anti-retroviral therapy.
by: Saif Ullah Munshi, et al.
Published: (2013-01-01) -
MicroRNA-150 (miR-150) and Diabetic Retinopathy: Is miR-150 Only a Biomarker or Does It Contribute to Disease Progression?
by: Gladys Y.-P. Ko, et al.
Published: (2022-10-01) -
Biomarker Potential of Plasma MicroRNA-150-5p in Prostate Cancer
by: Ionut Andrei Paunescu, et al.
Published: (2019-09-01) -
MicroRNA‐150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson's disease
by: Haiting Li, et al.
Published: (2020-04-01) -
Interplay between HIV and microRNAs in AIDS-related lymphomas
by: Onnis Anna, et al.
Published: (2010-05-01)